MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more

Mindray Presents Holistic IVD Solutions for Laboratories at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023

Image: The latest innovations and solutions on display at Medlab Middle East 2023 (Photo courtesy of Mindray)

Mindray (Shenzhen, China) is presenting the company’s holistic solutions in in-vitro diagnostics (IVD) at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

At Medlab Middle East 2023, Mindray is showcasing its total IVD solutions and new technologies that cater to laboratories with all sample volumes, ranging from large-sized laboratories to mid-sized and small-sized ones. Mindray is also demonstrating how its M6000 Laboratory Automation System can empower ultra high volume laboratories with high processing speed, less hands-on time, great cost efficiency and standardized analytical quality. Mindray is also presenting its ALL IN ONE Hematology Solution that brings greater efficiency to hematology testing with simplified workflows and ease of operation. It enables end-to-end automation throughout the process, from tube sorting through to analysis of CBC, ESR, CRP, SAA, and HbA1c with a single EDTA tube, smear preparation, and slide reading. The solution is ideal for core or centralized laboratories with mid-to-high sample volumes and a high demand for turnaround times.

Also on display at the show is the CAL 8000 New Generation Cellular Analysis Line from Mindray that provides more power for large-scale laboratories in the hematology area. It has a higher throughput per square meter, upgraded labXpert Data Management Software, flexible layout design options, and other advanced functionalities. Combining Mindray's new MC-80 Digital Cell Morphology Analyzer, the CAL 8000 is taking hematology analysis automation to the next level. Mindray is also presenting its BC-700 revolutionary hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests, alongside the BS-600M chemistry analyzer that combines cutting-edge medical technology with advanced clinical applications and service processes for the screening and treatment for chronic diseases.

Related Links:
Mindray